Incannex Healthcare (NASDAQ: IXHL) has completed patient dosing…
Continue ReadingCategory: Sleep Disorders Healthcare
Sleep Disorder Treatment Drugs Market Size Analysis,
Sleep Disorder Treatment Drugs Market The global Sleep Disorder Treatment Drugs Market was valued at approximately…
Continue Reading
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Patient dosing completed in Phase 2 portion of Phase 2/3 RePOSA study evaluating IHL-42X oral treatment…
Continue Reading
Shaping the Future of Sleep Apnea Diagnostics with Wearables
R. Kirk Huntsman, Chairman and CEO, Co-Founder at Vivos Therapeutics Sleep is essential, yet millions worldwide…
Continue Reading$186.97 Bn Sleeping Aids Market Opportunities and
Dublin, May 09, 2025 (GLOBE NEWSWIRE) — The “Sleeping Aids Market Opportunities and Strategies to 2034”…
Continue Reading
Racial Inequality of Sleep Among Black Women
Sleep disorders are prevalent across populations, but significant racial disparities persist. Compared with White individuals, Black…
Continue Reading